Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Relevance of total PSA and free PSA prescriptions.

Lamy PJ, Brouillet JP, Bermont L, Fouillet G, Loric S.

Ann Biol Clin (Paris). 2018 Dec 1;76(6):659-663. doi: 10.1684/abc.2018.1392. Review.

PMID:
30543191
2.

Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.

Bartolucci P, Habibi A, Khellaf M, Roudot-Thoraval F, Melica G, Lascaux AS, Moutereau S, Loric S, Wagner-Ballon O, Berkenou J, Santin A, Michel M, Renaud B, Lévy Y, Galactéros F, Godeau B.

EBioMedicine. 2016 Aug;10:305-11. doi: 10.1016/j.ebiom.2016.06.038. Epub 2016 Jun 29.

3.

[The level of evidence for the use of biomarkers in the early detection of prostate cancer].

Lamy PJ, Gauchez AS, Salomon L, Haugh M, Ceraline J, Fulla Y, Georges A, Larré S, Loric S, Luporsi E, Martin PM, Mazerolles C, Molinié V, Mongiat-Artus P, Piffret J, Thuillier F, Perrin P, Rebillard X; Groupe de biologie de la prostate.

Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):227-32. doi: 10.1684/abc.2016.1128. Review. French.

4.

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galacteros F, Audard V.

J Am Soc Nephrol. 2016 Jun;27(6):1847-53. doi: 10.1681/ASN.2014111126. Epub 2015 Nov 19.

5.

Haematological determinants of cardiac involvement in adults with sickle cell disease.

Damy T, Bodez D, Habibi A, Guellich A, Rappeneau S, Inamo J, Guendouz S, Gellen-Dautremer J, Pissard S, Loric S, Wagner-Ballon O, Godeau B, Adnot S, Dubois-Randé JL, Hittinger L, Galactéros F, Bartolucci P.

Eur Heart J. 2016 Apr 7;37(14):1158-1167. doi: 10.1093/eurheartj/ehv555. Epub 2015 Oct 29.

PMID:
26516176
6.

Evidence of estrone-sulfate uptake modification in young and middle-aged rat prostate.

Giton F, Sirab N, Franck G, Gervais M, Schmidlin F, Ali T, Allory Y, de la Taille A, Vacherot F, Loric S, Fiet J.

J Steroid Biochem Mol Biol. 2015 Aug;152:89-100. doi: 10.1016/j.jsbmb.2015.05.002. Epub 2015 May 6.

PMID:
25958048
7.

Biological parameters predictive of percent dense red blood cell decrease under hydroxyurea.

Rakotoson MG, Di Liberto G, Audureau E, Habibi A, Fauroux C, Khorgami S, Hulin A, Loric S, Noizat-Pirenne F, Galacteros F, Bartolucci P.

Orphanet J Rare Dis. 2015 May 9;10:57. doi: 10.1186/s13023-015-0272-3.

8.

First evidence of subclinical renal tubular injury during sickle-cell crisis.

Audard V, Moutereau S, Vandemelebrouck G, Habibi A, Khellaf M, Grimbert P, Levy Y, Loric S, Renaud B, Lang P, Godeau B, Galactéros F, Bartolucci P.

Orphanet J Rare Dis. 2014 Apr 29;9:67. doi: 10.1186/1750-1172-9-67.

9.

Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis.

Damy T, Deux JF, Moutereau S, Guendouz S, Mohty D, Rappeneau S, Guellich A, Hittinger L, Loric S, Lefaucheur JP, Plante-Bordeneuve V.

Amyloid. 2013 Dec;20(4):212-20. doi: 10.3109/13506129.2013.825240. Epub 2013 Aug 21.

10.

Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.

Chousterman BG, Bouadma L, Moutereau S, Loric S, Alvarez-Gonzalez A, Mekontso-Dessap A, Laissy JP, Rahmouni A, Katsahian S, Brochard L, Schortgen F.

J Crit Care. 2013 Oct;28(5):701-9. doi: 10.1016/j.jcrc.2013.03.007. Epub 2013 May 15.

PMID:
23683568
11.

The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy.

Durand X, Xylinas E, Radulescu C, Haus-Cheymol R, Moutereau S, Ploussard G, Forgues A, Robert G, Vacherot F, Loric S, Allory Y, Ruffion A, de la Taille A.

BJU Int. 2012 Jul;110(1):43-9. doi: 10.1111/j.1464-410X.2011.10682.x. Epub 2012 Jan 5.

12.

Androgens regulate Hedgehog signalling and proliferation in androgen-dependent prostate cells.

Sirab N, Terry S, Giton F, Caradec J, Chimingqi M, Moutereau S, Vacherot F, de la Taille A, Kouyoumdjian JC, Loric S.

Int J Cancer. 2012 Sep 15;131(6):1297-306. doi: 10.1002/ijc.27384. Epub 2012 Jan 27.

13.

[Ischemic lesions in kidneys after extracorporeal shock wave lithotripsy demonstrated by Proton NMR spectroscopy of urine samples].

Berte N, Cayzergues L, Meyer F, Jira H, Eugene M, Conti M, Loric S, Hammoudi Y, Benoit G, Droupy S, Hubert J, Eschwege P.

Prog Urol. 2011 Jul;21(7):455-8. doi: 10.1016/j.purol.2011.02.009. Epub 2011 Apr 3. French.

PMID:
21693355
14.

A bias in quantitative RT-PCR limit of detection is induced by the use of cancer cell lines in the molecular detection of circulating tumor cells.

Prost à la Denise J, Dekairelle AF, Desbene C, Moutereau S, Douard R, Devanlay M, Eschwege P, Gala JL, Loric S.

Clin Chem Lab Med. 2011 Jun;49(6):1073-5. doi: 10.1515/CCLM.2011.175. No abstract available.

PMID:
21649554
15.

Improved neopterin ELISA kit: a good compromise between HPLC results and clinical practice.

Moutereau S, Ech Chad N, Devanlay M, Esmilaire L, Loric S.

Clin Chem Lab Med. 2011 Mar;49(3):553-4. doi: 10.1515/CCLM.2011.071. Epub 2011 Feb 11. No abstract available.

PMID:
21309728
16.

Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance.

Ploussard G, Durand X, Xylinas E, Moutereau S, Radulescu C, Forgue A, Nicolaiew N, Terry S, Allory Y, Loric S, Salomon L, Vacherot F, de la Taille A.

Eur Urol. 2011 Mar;59(3):422-9. doi: 10.1016/j.eururo.2010.11.044. Epub 2010 Dec 8.

PMID:
21156337
17.

Is GAPDH a relevant housekeeping gene for normalisation in colorectal cancer experiments?

Caradec J, Sirab N, Revaud D, Keumeugni C, Loric S.

Br J Cancer. 2010 Oct 26;103(9):1475-6. doi: 10.1038/sj.bjc.6605851. Epub 2010 Sep 21. No abstract available.

18.

Renoprotective potency of amifostine in rat renal ischaemia-reperfusion.

Chok MK, Conti M, Almolki A, Ferlicot S, Loric S, Dürrbach A, Benoît G, Droupy S, Eschwège P.

Nephrol Dial Transplant. 2010 Dec;25(12):3845-51. doi: 10.1093/ndt/gfq314. Epub 2010 Jun 4.

PMID:
20525975
19.

'Desperate house genes': the dramatic example of hypoxia.

Caradec J, Sirab N, Keumeugni C, Moutereau S, Chimingqi M, Matar C, Revaud D, Bah M, Manivet P, Conti M, Loric S.

Br J Cancer. 2010 Mar 16;102(6):1037-43. doi: 10.1038/sj.bjc.6605573. Epub 2010 Feb 23.

20.

Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C.

Conti M, Moutereau S, Esmilaire L, Desbene C, Lallali K, Devanlay M, Durrbach A, Manivet P, Eschwège P, Loric S.

Clin Chem Lab Med. 2009;47(12):1553-6. doi: 10.1515/CCLM.2009.341.

PMID:
19877765
21.

Renoprotective potency of heme oxygenase-1 induction in rat renal ischemia-reperfusion.

Chok MK, Ferlicot S, Conti M, Almolki A, Dürrbach A, Loric S, Benoît G, Droupy S, Eschwège P.

Inflamm Allergy Drug Targets. 2009 Sep;8(4):252-9.

PMID:
19754408
22.

Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study.

Eschwège P, Moutereau S, Droupy S, Douard R, Gala JL, Benoit G, Conti M, Manivet P, Loric S.

Br J Cancer. 2009 Feb 24;100(4):608-10. doi: 10.1038/sj.bjc.6604912.

23.

[Statins: hepatotoxicity and monitoring].

Cadranel JF, Seddik M, Loric S, Jeanne S.

Presse Med. 2009 May;38(5):717-25. doi: 10.1016/j.lpm.2008.05.022. Epub 2008 Dec 25. French.

PMID:
19111435
24.

Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression.

Azoulay S, Terry S, Chimingqi M, Sirab N, Faucon H, Gil Diez de Medina S, Moutereau S, Maillé P, Soyeux P, Abbou C, Salomon L, Vacherot F, de La Taille A, Loric S, Allory Y.

J Pathol. 2008 Dec;216(4):460-70. doi: 10.1002/path.2427.

PMID:
18825689
25.

Elucidation of the natural artemisinin decomposition route upon iron interaction: a fine electronic redistribution promotes reactivity.

Nosoongnoen W, Pratuangdejkul J, Sathirakul K, Jacob A, Conti M, Loric S, Launay JM, Manivet P.

Phys Chem Chem Phys. 2008 Sep 1;10(33):5083-93. doi: 10.1039/b804516j. Epub 2008 Jun 25.

PMID:
18701956
26.

Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa).

Giton F, de la Taille A, Allory Y, Galons H, Vacherot F, Soyeux P, Abbou CC, Loric S, Cussenot O, Raynaud JP, Fiet J.

J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):158-67. doi: 10.1016/j.jsbmb.2007.10.005. Epub 2008 Feb 8.

PMID:
18337090
27.

[Molecular pharmacogenetics in hospital laboratories in France: current data and future prospects].

Allorge D, Beaune PH, Becquemont L, Bessard G, Bezieau S, Boisdron-Celle M, Boyer JC, Broly F, Dhaneens CM, Fonrose X, Gagnieu MC, Gamelin E, Gozé C, Jacqz-Aigrain E, Loric S, Loriot MA, Marquet P, Morel A, Namour B, Paintaud G, Peoc'h K, Picard N, Watier H, Verstuyft C.

Ann Pharm Fr. 2007 Nov;65(6):371-81. Review. French.

PMID:
18079669
28.

Specific real-time PCR vs. fluorescent dyes for serum free DNA quantification.

Chiminqgi M, Moutereau S, Pernet P, Conti M, Barbu V, Lemant J, Sacko M, Vaubourdolle M, Loric S.

Clin Chem Lab Med. 2007;45(8):993-5.

PMID:
17867987
29.

Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction.

Lim P, Collet JP, Moutereau S, Guigui N, Mitchell-Heggs L, Loric S, Bernard M, Benhamed S, Montalescot G, Randé JL, Guéret P.

Clin Chem. 2007 Oct;53(10):1835-40. Epub 2007 Aug 16.

30.

The use of intravenous catheterisation with a rest period is useful for determination of plasma cortisol levels but not plasma prolactin levels.

Briet C, Saraval M, Loric S, Topolinski-Duyme H, Fendri S, Desailloud R.

Ann Endocrinol (Paris). 2007 Feb;68(1):34-8. Epub 2007 Feb 21.

PMID:
17316543
31.
32.

Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer.

Douard R, Moutereau S, Pernet P, Chimingqi M, Allory Y, Manivet P, Conti M, Vaubourdolle M, Cugnenc PH, Loric S.

Surgery. 2006 May;139(5):665-70.

PMID:
16701100
33.

Gefitinib inhibits the growth and invasion of urothelial carcinoma cell lines in which Akt and MAPK activation is dependent on constitutive epidermal growth factor receptor activation.

Nicolle G, Daher A, Maillé P, Vermey M, Loric S, Bakkar A, Wallerand H, Vordos D, Vacherot F, de Medina SG, Abbou CC, Van der Kwast T, Thiery JP, Radvanyi F, Chopin DK.

Clin Cancer Res. 2006 May 1;12(9):2937-43.

34.

Cation-π Interactions in Serotonin:  Conformational, Electronic Distribution, and Energy Decomposition Analysis.

Pratuangdejkul J, Jaudon P, Ducrocq C, Nosoongnoen W, Guerin GA, Conti M, Loric S, Launay JM, Manivet P.

J Chem Theory Comput. 2006 May;2(3):746-60. doi: 10.1021/ct0600316.

PMID:
26626679
35.

Long-term prognostic value of detection of circulating colorectal cancer cells using CGM2 reverse transcriptase-polymerase chain reaction assay.

Douard R, Wind P, Sales JP, Landi B, Berger A, Benichou J, Gayral F, Loric S, Cugnenc PH.

Surgery. 2006 Apr;139(4):556-62.

PMID:
16627067
36.

Urinary cystatin C as a specific marker of tubular dysfunction.

Conti M, Moutereau S, Zater M, Lallali K, Durrbach A, Manivet P, Eschwège P, Loric S.

Clin Chem Lab Med. 2006;44(3):288-91.

PMID:
16519600
37.

Definition of an uptake pharmacophore of the serotonin transporter through 3D-QSAR analysis.

Pratuangdejkul J, Schneider B, Jaudon P, Rosilio V, Baudoin E, Loric S, Conti M, Launay JM, Manivet P.

Curr Med Chem. 2005;12(20):2393-410.

PMID:
16181139
38.

Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients.

Douard R, Moutereau S, Serru V, Sales JP, Wind P, Cugnenc PH, Vaubourdolle M, Loric S.

Clin Chem Lab Med. 2005;43(2):127-32.

PMID:
15843204
39.

Re: "Detection and prognostic relevance of cytokeratin 20 in differentiated and anaplastic thyroid carcinomas by RT-PCR".

Douard R, Moutereau S, Wind P, Berger A, Cugenec PH, Loric S.

Surgery. 2005 Jan;137(1):123. No abstract available.

PMID:
15614295
40.

Absence of circadian variations in urine cystatin C allows its use on urinary samples.

Conti M, Zater M, Lallali K, Durrbach A, Moutereau S, Manivet P, Eschwège P, Loric S.

Clin Chem. 2005 Jan;51(1):272-3. No abstract available.

41.

Unexpected high frequency of P46L TNFRSF1A allele in sub-Saharan West African populations.

Tchernitchko D, Chiminqgi M, Galactéros F, Préhu C, Segbena Y, Coulibaly H, Rebaya N, Loric S.

Eur J Hum Genet. 2005 Apr;13(4):513-5.

42.

[RT-PCR in clinical diagnosis].

Cavé H, Acquaviva C, Bièche I, Brault D, de Fraipont F, Fina F, Loric S, Maisonneuve L, Namour F, Tuffery S.

Ann Biol Clin (Paris). 2003 Nov-Dec;61(6):635-44. Review. French.

43.

A histopathologic investigation of PGE(2) pathways as predictors of proliferation and invasion in urothelial carcinomas of the bladder.

Eschwège P, Ferlicot S, Droupy S, Ba N, Conti M, Loric S, Coindard G, Denis I, Ferretti L, Cornelius A, Legrand A, Bedossa P, Benoît G, Jardin A, Scardino P.

Eur Urol. 2003 Oct;44(4):435-41.

PMID:
14499677
44.

Total situs inversus: a genetic material bank as a new tool for anatomical research.

Douard R, Chevallier JM, Loric S, Cugnenc PH, Delmas V.

Surg Radiol Anat. 2003 Jul-Aug;25(3-4):173-4. Epub 2003 Jul 26. No abstract available.

PMID:
12898198
45.

Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy.

Tombal B, Van Cangh PJ, Loric S, Gala JL.

Prostate. 2003 Aug 1;56(3):163-70.

PMID:
12772185
46.

Autologous blood transfusion as a potential source of prostate cancer cells spread during radical prostatectomy.

Eschwège P, Dumas F, Benoît G, Loric S.

Prostate Cancer Prostatic Dis. 1999 Nov;2(S3):S13. No abstract available.

47.

Expression of cyclooxygenase 2 and prostaglandin E synthase after renal ischemia-reperfusion.

Slimane MA, Ferlicot S, Conti M, Droupy S, Cosson C, Paradis V, Loric S, Bedossa P, Gauthier F, Legrand A, Benoît G, Eschwège P.

Transplant Proc. 2002 Nov;34(7):2841-2. No abstract available.

PMID:
12431630
48.

Value of lipid peroxidation by-products detected during the renal procurement on renal graft function.

Eschwège P, Droupy S, Conti M, Ferlicot S, Paradis V, Loric S, Bedossa P, Duranteau J, Durrbach A, Legrand A, Charpentier B, Benoît G.

Transplant Proc. 2002 Nov;34(7):2840. No abstract available.

PMID:
12431629
49.

[RNA isolation and purification methods].

Bastard JP, Chambert S, Ceppa F, Coude M, Grapez E, Loric S, Muzeau F, Spyratos F, Poirier K, Copois V, Tse C, Bienvenu T; Groupe de travail de la SFBC.

Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):513-23. Review. French.

50.

Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer.

Loric S, Paradis V, Gala JL, Berteau P, Bedossa P, Benoit G, Eschwège P.

Eur J Cancer. 2001 Aug;37(12):1475-81.

PMID:
11506953

Supplemental Content

Support Center